The challenges of changing national malaria drug policy to artemisinin-based combinations in Kenya

BACKGOUND: Sulphadoxine/sulphalene-pyrimethamine (SP) was adopted in Kenya as first line therapeutic for uncomplicated malaria in 1998. By the second half of 2003, there was convincing evidence that SP was failing and had to be replaced. Despite several descriptive investigations of policy change an...

Descripción completa

Detalles Bibliográficos
Autores principales: Amin, Abdinasir A, Zurovac, Dejan, Kangwana, Beth B, Greenfield, Joanne, Otieno, Dorothy N, Akhwale, Willis S, Snow, Robert W
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1892027/
https://www.ncbi.nlm.nih.gov/pubmed/17535417
http://dx.doi.org/10.1186/1475-2875-6-72

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1892027/
https://www.ncbi.nlm.nih.gov/pubmed/17535417
http://dx.doi.org/10.1186/1475-2875-6-72

Ejemplares similares